Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,743,372
  • Shares Outstanding, K 101,045
  • Annual Sales, $ 136,470 K
  • Annual Income, $ -254,340 K
  • 60-Month Beta 2.68
  • Price/Sales 19.34
  • Price/Cash Flow N/A
  • Price/Book 11.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.58
  • Number of Estimates 4
  • High Estimate -0.43
  • Low Estimate -0.67
  • Prior Year -0.81
  • Growth Rate Est. (year over year) +28.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.21 +6.07%
on 07/14/20
29.92 -10.63%
on 07/06/20
-2.83 (-9.57%)
since 07/02/20
3-Month
22.65 +18.06%
on 05/07/20
30.18 -11.40%
on 06/23/20
+1.88 (+7.56%)
since 05/04/20
52-Week
12.09 +121.17%
on 03/17/20
34.94 -23.47%
on 02/06/20
+9.33 (+53.59%)
since 08/02/19

Most Recent Stories

More News
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release...

INSM : 26.74 (-1.51%)
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infections Caused by MAC in Non-CF Patients with Limited Treatment Options

, /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the Committee...

INSM : 26.74 (-1.51%)
Insmed Inc Up 47.7% Since SmarTrend Uptrend Call (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 4 months, Insmed Inc has returned 47.69% as of today's recent price of $26.40.

INSM : 26.74 (-1.51%)
Insmed Inc Up 52.3% Since SmarTrend Uptrend Call (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 4 months, Insmed Inc has returned 52.34% as of today's recent price of $27.23.

INSM : 26.74 (-1.51%)
Look for Shares of Insmed Inc to Potentially Rebound after Yesterday's 1.56% Sell Off

Insmed Inc (NASDAQ:INSM) traded in a range yesterday that spanned from a low of $25.21 to a high of $26.38. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $27.09...

INSM : 26.74 (-1.51%)
Amgen (AMGN) Invests Further in China-Based Oncology Partner

Amgen (AMGN) announces additional investment of approximately $421 million in BeiGene. The companies have a collaboration for oncology products signed in 2019.

IMMU : 44.14 (-0.61%)
AMGN : 243.59 (-1.52%)
INSM : 26.74 (-1.51%)
BGNE : 222.65 (+0.44%)
Insmed Inc Shares Up 56.1% Since SmarTrend's Buy Recommendation (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 4 months, Insmed Inc has returned 56.08% as of today's recent price of $27.90.

INSM : 26.74 (-1.51%)
New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patients with Refractory MAC Lung Disease

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that ARIKAYCE (amikacin...

INSM : 26.74 (-1.51%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of...

INSM : 26.74 (-1.51%)
Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at ATS Virtual Clinical Trials Session

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that final results...

INSM : 26.74 (-1.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INSM with:

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

2nd Resistance Point 27.55
1st Resistance Point 27.14
Last Price 26.74
1st Support Level 26.43
2nd Support Level 26.12

See More

52-Week High 34.94
Last Price 26.74
Fibonacci 61.8% 26.21
Fibonacci 50% 23.51
Fibonacci 38.2% 20.82
52-Week Low 12.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar